Rapid tests market to reach $59.06 billion by 2030

The Business Research Company projects the rapid tests market will grow from $34.67 billion in 2025 to $59.06 billion by 2030, fueled by infectious-disease detection demand, point-of-care expansion and new testing tech. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Rapid tests are becoming a bigger part of healthcare delivery because they can identify diseases and conditions in minutes without complex lab equipment. - Faster diagnosis can speed treatment decisions, support isolation measures and help limit the spread of infectious diseases. - The market’s projected expansion points to stronger demand for point-of-care diagnostics across clinics, pharmacies and home settings.

What happened: - The Business Research Company released a rapid tests market report on Aug. 25, 2026. - The report projects the global rapid tests market will rise from $34.67 billion in 2025 to $38.66 billion in 2026. - The report forecasts the market will reach $59.06 billion by 2030. - The report estimates a 11.5% compound annual growth rate from 2025 to 2026 and 11.2% from 2026 to 2030. - Download a free sample of the rapid tests market report. - View the full rapid tests market report.

The details: - Rapid tests are diagnostic devices designed to identify specific diseases or health conditions quickly, often within minutes to an hour. - The tests usually require minimal equipment and can be used in clinics, pharmacies or at home. - The report ties current growth to demand for fast disease detection, better lateral flow assays, preventive healthcare awareness, expanding healthcare infrastructure in emerging markets and rising infectious-disease prevalence. - Future growth is expected to be supported by AI and IoT integration, wider home healthcare use, multiplex testing kits, personalized medicine and government policies that favor point-of-care diagnostics. - The report highlights point-of-care testing expansion, device miniaturization, faster infectious-disease screening, home-based diagnostics and lower-cost testing as major trends. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing region during the forecast period. - The regional analysis also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables. - The Business Research Company listed contact details for Saumya Sahay, including phone numbers for the Americas, Asia and Europe, and the email marketing@tbrc.info. - The Business Research Company also provided social links on LinkedIn, Facebook and X.

Between the lines: - Infectious-disease pressure remains a major driver for rapid diagnostics, and the report uses tuberculosis data in England to illustrate that demand. - The UK Health Security Agency reported 4,850 tuberculosis cases in England in 2023, up 10.7% from 4,380 cases in 2022. - The forecast suggests the market is moving from basic quick testing toward more connected, automated and home-friendly tools.

What's next: - The report expects continued adoption of rapid tests as healthcare systems push diagnostics closer to patients. - Growth in emerging markets and home healthcare could open additional demand for portable and affordable test formats. - New product development is likely to focus on faster, smaller and more multiplex testing platforms. - The market’s next inflection points will likely come from how quickly AI, IoT and supportive policy translate into real-world adoption.